Literature DB >> 22135261

Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.

Ulla Jounio1, Annika Saukkoriipi, Holly B Bratcher, Aini Bloigu, Raija Juvonen, Sylvi Silvennoinen-Kassinen, Ari Peitso, Terttu Harju, Olli Vainio, Markku Kuusi, Martin C J Maiden, Maija Leinonen, Helena Käyhty, Maija Toropainen.   

Abstract

The relationship between carriage and the development of invasive meningococcal disease is not fully understood. We investigated the changes in meningococcal carriage in 892 military recruits in Finland during a nonepidemic period (July 2004 to January 2006) and characterized all of the oropharyngeal meningococcal isolates obtained (n = 215) by using phenotypic (serogrouping and serotyping) and genotypic (porA typing and multilocus sequence typing) methods. For comparison, 84 invasive meningococcal disease strains isolated in Finland between January 2004 and February 2006 were also analyzed. The rate of meningococcal carriage was significantly higher at the end of military service than on arrival (18% versus 2.2%; P < 0.001). Seventy-four percent of serogroupable carriage isolates belonged to serogroup B, and 24% belonged to serogroup Y. Most carriage isolates belonged to the carriage-associated ST-60 clonal complex. However, 21.5% belonged to the hyperinvasive ST-41/44 clonal complex. Isolates belonging to the ST-23 clonal complex were cultured more often from oropharyngeal samples taken during the acute phase of respiratory infection than from samples taken at health examinations at the beginning and end of military service (odds ratio [OR], 6.7; 95% confidence interval [95% CI], 2.7 to 16.4). The ST-32 clonal complex was associated with meningococcal disease (OR, 17.8; 95% CI, 3.8 to 81.2), while the ST-60 clonal complex was associated with carriage (OR, 10.7; 95% CI, 3.3 to 35.2). These findings point to the importance of meningococcal vaccination for military recruits and also to the need for an efficacious vaccine against serogroup B isolates.

Entities:  

Mesh:

Year:  2011        PMID: 22135261      PMCID: PMC3264188          DOI: 10.1128/JCM.05385-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.

Authors:  M Toropainen; L Saarinen; P van der Ley; B Kuipers; H Käyhty
Journal:  Microb Pathog       Date:  2001-03       Impact factor: 3.738

Review 2.  Dynamics of bacterial carriage and disease: lessons from the meningococcus.

Authors:  Martin C J Maiden
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

3.  Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010.

Authors:  S Thulin Hedberg; B Törös; H Fredlund; P Olcén; P Mölling
Journal:  Euro Surveill       Date:  2011-06-09

4.  The meningococcal carrier-rate.

Authors:  P K Fraser; G K Bailey; J D Abbott; J B Gill; D J Walker
Journal:  Lancet       Date:  1973-06-02       Impact factor: 79.321

5.  The changing epidemiology of meningococcal disease in the United States, 1992-1996.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; L Lefkowitz; M L Cartter; R Danila; P Cieslak; K A Shutt; T Popovic; A Schuchat; L H Harrison; A L Reingold
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

Review 6.  Neisseria meningitidis: an overview of the carriage state.

Authors:  Siamak P Yazdankhah; Dominique A Caugant
Journal:  J Med Microbiol       Date:  2004-09       Impact factor: 2.472

7.  Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers.

Authors:  D A Caugant; B E Kristiansen; L O Frøholm; K Bøvre; R K Selander
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

8.  Survival of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis frozen in skim milk- tryptone-glucose-glycerol medium.

Authors:  Tarja Kaijalainen; Esa Ruokokoski; Pentti Ukkonen; Elja Herva
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 9.  Sampling methods to detect carriage of Neisseria meningitidis; literature review.

Authors:  Jonathan Roberts; Brian Greenwood; James Stuart
Journal:  J Infect       Date:  2009-01-24       Impact factor: 6.072

10.  Genealogical typing of Neisseria meningitidis.

Authors:  Xavier Didelot; Rachel Urwin; Martin C J Maiden; Daniel Falush
Journal:  Microbiology (Reading)       Date:  2009-07-30       Impact factor: 2.777

View more
  13 in total

1.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

2.  Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil.

Authors:  Ana Rafaela Silva Simões Moura; Cécilia Batmalle Kretz; Italo Eustáquio Ferreira; Amélia Maria Pithon Borges Nunes; José Cássio de Moraes; Mitermayer Galvão Reis; Alan John Alexander McBride; Xin Wang; Leila Carvalho Campos
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

3.  Molecular characterization of Neisseria meningitidis isolates recovered from patients with invasive meningococcal disease in Colombia from 2013 to 2016.

Authors:  Jaime Moreno; Zonia Alarcon; Eliana Parra; Carolina Duarte; Olga Sanabria; Diego Prada; Jean Marc Gabastou
Journal:  PLoS One       Date:  2020-07-14       Impact factor: 3.240

4.  Rare Case of Community-Acquired Endocarditis Caused by Neisseria meningitidis Assessed by Clinical Metagenomics.

Authors:  Vassili Choutko; Vladimir Lazarevic; Nadia Gaïa; Myriam Girard; Gesuele Renzi; Stefano Leo; Peter M Keller; Christoph Huber; Jacques Schrenzel
Journal:  Front Cardiovasc Med       Date:  2019-08-06

5.  B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia.

Authors:  Mark McMillan; Luke Walters; Turra Mark; Andrew Lawrence; Lex E X Leong; Thomas Sullivan; Geraint B Rogers; Ross M Andrews; Helen S Marshall
Journal:  Hum Vaccin Immunother       Date:  2019-01-04       Impact factor: 3.452

6.  Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia).

Authors:  Jaime Moreno; Melissa Hidalgo; Carolina Duarte; Olga Sanabria; Jean Marc Gabastou; Ana Belén Ibarz-Pavon
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

7.  Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.

Authors:  Annaliesa S Anderson; Li Hao; Qin Jiang; Shannon L Harris; Thomas R Jones; John L Perez; Laura York; Joseph Eiden; Kathrin U Jansen
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

8.  Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

Authors:  Carina Brehony; Caroline L Trotter; Mary E Ramsay; Manosree Chandra; Keith A Jolley; Arie van der Ende; Françoise Carion; Lene Berthelsen; Steen Hoffmann; Hjördís Harðardóttir; Julio A Vazquez; Karen Murphy; Maija Toropainen; Manuela Caniça; Eugenia Ferreira; Mathew Diggle; Giles F Edwards; Muhamed-Kheir Taha; Paola Stefanelli; Paula Kriz; Steve J Gray; Andrew J Fox; Susanne Jacobsson; Heike Claus; Ulrich Vogel; Georgina Tzanakaki; Sigrid Heuberger; Dominique A Caugant; Matthias Frosch; Martin C J Maiden
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

9.  The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta.

Authors:  David Pace; Charmaine Gauci; Christopher Barbara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-05-16       Impact factor: 3.267

10.  Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.

Authors:  Margherita Bodini; Alessandro Brozzi; Maria Giuliani; Hanna Nohynek; Anni Vainio; Markku Kuusi; Rosita De Paola; Mariagrazia Pizza; Duccio Medini; Maija Toropainen; Laura Serino; Alessandro Muzzi
Journal:  mSphere       Date:  2020-09-16       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.